Bioactive Lipodepsipeptides Produced by Bacteria and Fungi

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Oct 27

PMID 36293201

Authors

Antonio Evidente

Affiliations

Soon will be listed here.

Abstract

Natural products are a vital source for agriculture, medicine, cosmetics and other fields. Lipodepsipeptides (LPDs) are a wide group of natural products distributed among living organisms such as bacteria, fungi, yeasts, virus, insects, plants and marine organisms. They are a group of compounds consisting of a lipid connected to a peptide, which are able to self-assemble into several different structures. They have shown different biological activities such as phytotoxic, antibiotic, antiviral, antiparasitic, antifungal, antibacterial, immunosuppressive, herbicidal, cytotoxic and hemolytic activities. Their biological activities seem to be due to their interactions with the plasma membrane (MP) because they are able to mimic the architecture of the native membranes interacting with their hydrophobic segment. LPDs also have surfactant properties. The review has been focused on the lipodepsipeptides isolated from fungal and bacterial sources, on their biological activity, on the structure-activity relationships of some selected LPD subgroups and on their potential application in agriculture and medicine. The chemical and biological characterization of lipodepsipeptides isolated in the last three decades and findings that resulted from SCI-FINDER research are reported. A critical evaluation of the most recent reviews dealing with the same argument has also been described.

Citing Articles

Advances on Bioactive Metabolites with Potential for the Biocontrol of Plant Pathogenic Bacteria.

Reveglia P, Corso G, Evidente A Pathogens. 2024; 13(11).

PMID: 39599553 PMC: 11597488. DOI: 10.3390/pathogens13111000.

The Epiphyte sp. G2112 Produces a Large Diversity of Nobilamide Peptides That Promote Biofilm Formation in Pseudomonads and .

Iloabuchi K, Spiteller D Biomolecules. 2024; 14(10).

PMID: 39456177 PMC: 11505918. DOI: 10.3390/biom14101244.

Advances on anticancer fungal metabolites: sources, chemical and biological activities in the last decade (2012-2023).

Evidente A Nat Prod Bioprospect. 2024; 14(1):31.

PMID: 38743184 PMC: 11093966. DOI: 10.1007/s13659-024-00452-0.

A comprehensive computational study to explore promising natural bioactive compounds targeting glycosyltransferase MurG in Escherichia coli for potential drug development.

Shtaiwi A, Khan S, Khedraoui M, Alaraj M, Samadi A, Chtita S Sci Rep. 2024; 14(1):7098.

PMID: 38532068 PMC: 10966019. DOI: 10.1038/s41598-024-57702-x.

Uncovering Phytotoxic Compounds Produced by spp. Involved in Legume Diseases Using an OSMAC-Metabolomics Approach.

Reveglia P, Agudo-Jurado F, Barilli E, Masi M, Evidente A, Rubiales D J Fungi (Basel). 2023; 9(6).

PMID: 37367546 PMC: 10302859. DOI: 10.3390/jof9060610.

References

Newman D, Cragg G . Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803. DOI: 10.1021/acs.jnatprod.9b01285. View

Hamamoto H, Urai M, Ishii K, Yasukawa J, Paudel A, Murai M . Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane. Nat Chem Biol. 2014; 11(2):127-33. DOI: 10.1038/nchembio.1710. View

Xie Y, Wright S, Shen Y, Du L . Bioactive natural products from Lysobacter. Nat Prod Rep. 2012; 29(11):1277-87. PMC: 3468324. DOI: 10.1039/c2np20064c. View

Brumbley S, Carney B, Denny T . Phenotype conversion in Pseudomonas solanacearum due to spontaneous inactivation of PhcA, a putative LysR transcriptional regulator. J Bacteriol. 1993; 175(17):5477-87. PMC: 206604. DOI: 10.1128/jb.175.17.5477-5487.1993. View

Cheng M, Huang J, Ramu S, Butler M, Cooper M . Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother. 2014; 58(11):6819-27. PMC: 4249368. DOI: 10.1128/AAC.00061-14. View

Cimmino A, Roscetto E, Masi M, Tuzi A, Radjai I, Gahdab C . Sesquiterpene Lactones from with Antibiotic Activity against Clinical Isolates of . Antibiotics (Basel). 2021; 10(7). PMC: 8300741. DOI: 10.3390/antibiotics10070819. View

Ratnayake R, Fremlin L, Lacey E, Gill J, Capon R . Acremolides A-D, lipodepsipeptides from an Australian marine-derived fungus, Acremonium sp. J Nat Prod. 2008; 71(3):403-8. DOI: 10.1021/np070589g. View

Lee W, Schaefer K, Qiao Y, Srisuknimit V, Steinmetz H, Muller R . The Mechanism of Action of Lysobactin. J Am Chem Soc. 2015; 138(1):100-3. PMC: 4817722. DOI: 10.1021/jacs.5b11807. View

Ballio A, Barra D, Bossa F, Collina A, Grgurina I, Marino G . Syringopeptins, new phytotoxic lipodepsipeptides of Pseudomonas syringae pv. syringae. FEBS Lett. 1991; 291(1):109-12. DOI: 10.1016/0014-5793(91)81115-o. View

10.

GROUPE V, PUGH L, Weiss D, Kochi M . Observations on antiviral activity of viscosin. Proc Soc Exp Biol Med. 1951; 78(1):354-8. DOI: 10.3181/00379727-78-19071. View

11.

Isogai A, Iguchi H, Nakayama J, Kusai A, Takemoto J, Suzuki A . Structural analysis of new syringopeptins by tandem mass spectrometry. Biosci Biotechnol Biochem. 1995; 59(7):1374-6. DOI: 10.1271/bbb.59.1374. View

12.

Pedras M, Ismail N, Quail J, Boyetchko S . Structure, chemistry, and biological activity of pseudophomins A and B, new cyclic lipodepsipeptides isolated from the biocontrol bacterium Pseudomonas fluorescens. Phytochemistry. 2003; 62(7):1105-14. DOI: 10.1016/s0031-9422(02)00617-9. View

13.

Hashizume H, Igarashi M, Hattori S, Hori M, Hamada M, Takeuchi T . Tripropeptins, novel antimicrobial agents produced by Lysobacter sp. I. Taxonomy, isolation and biological activities. J Antibiot (Tokyo). 2002; 54(12):1054-9. DOI: 10.7164/antibiotics.54.1054. View

14.

CAVALLERI B, PAGANI H, Volpe G, Selva E, Parenti F . A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics. J Antibiot (Tokyo). 1984; 37(4):309-17. DOI: 10.7164/antibiotics.37.309. View

15.

MacIntyre L, Marchbank D, Correa H, Kerr R . Fusaristatin C, a Cyclic Lipodepsipeptide from Pithomyces sp. RKDO 1698. J Nat Prod. 2018; 81(12):2768-2772. DOI: 10.1021/acs.jnatprod.8b00787. View

16.

Coraiola M, Cantore P, Lazzaroni S, Evidente A, Iacobellis N, Dalla Serra M . WLIP and tolaasin I, lipodepsipeptides from Pseudomonas reactans and Pseudomonas tolaasii, permeabilise model membranes. Biochim Biophys Acta. 2006; 1758(11):1713-22. DOI: 10.1016/j.bbamem.2006.06.023. View

17.

Ishidoh K, Kinoshita H, Igarashi Y, Ihara F, Nihira T . Cyclic lipodepsipeptides verlamelin A and B, isolated from entomopathogenic fungus Lecanicillium sp. J Antibiot (Tokyo). 2014; 67(6):459-63. DOI: 10.1038/ja.2014.22. View

18.

Bensaci M, Gurnev P, Bezrukov S, Takemoto J . Fungicidal Activities and Mechanisms of Action of Pseudomonas syringae pv. syringae Lipodepsipeptide Syringopeptins 22A and 25A. Front Microbiol. 2011; 2:216. PMC: 3201023. DOI: 10.3389/fmicb.2011.00216. View

19.

Ganley J, Carr G, Ioerger T, Sacchettini J, Clardy J, Derbyshire E . Discovery of Antimicrobial Lipodepsipeptides Produced by a Serratia sp. within Mosquito Microbiomes. Chembiochem. 2018; 19(15):1590-1594. DOI: 10.1002/cbic.201800124. View

20.

Cimmino A, Masi M, Evidente M, Superchi S, Evidente A . Fungal phytotoxins with potential herbicidal activity: chemical and biological characterization. Nat Prod Rep. 2015; 32(12):1629-53. DOI: 10.1039/c5np00081e. View